TRIPHALA GHRITA IN THE MANAGEMENT OF PARIKARTIKA WITH SPECIAL REFERENCE TO FISSURE-IN-ANO: A SINGLE-BLIND RANDOMIZED CLINICAL STUDY
DOI:
https://doi.org/10.70057/ijaar.2026.71001Keywords:
anal fissure, Constipation, Ayurvedic drugs, Shalyatantra, clinical outcome, anorectal disorderAbstract
Background: In Ayurvedic literature, Parikartika is associated with a cutting or tearing type of pain in the anal region and may be clinically considered alongside fissure-in-ano. The present study examined clinical changes recorded in patients treated with Triphala Ghrita. Objective: To examine the changes in clinical features following Triphala Ghrita administration in patients diagnosed with Parikartika, considered with reference to fissure-in-ano. Methods: Thirty-five subjects were registered for the study and 30 patients who completed the treatment course were included in the final analysis. Participants aged 20–60 years who fulfilled the clinical diagnostic criteria for Parikartika were included in the study. They received Triphala Ghrita orally at a dose of 20 mL twice daily for 15 days, followed by a further 15-day observation period. Pain, burning sensation, bleeding and constipation were assessed on a 0-3 severity scale, and lesion size was assessed as an objective parameter. Pre-treatment and post-treatment scores were compared using the paired Student's t-test
Results: The mean pain score changed from 1.90 before treatment to 0.53 afterwards (reported improvement 71.92%; t=12.17, P<0.001). Burning scores changed from 1.60 to 0.56 (64.58%; t=8.46, P<0.001, bleeding from 1.50 to 0.60 (60.00%; t=9.00, P<0.001), constipation from 1.63 to 0.60(63.26%, t=9.20, P<0.001), and lesion size score from 7.53 to 2.03 (reported improvement 73.00%; t=28.02, P<0.001). Conclusion: Oral Triphala Ghrita was associated with statistically significant within-group improvement in the assessed clinical parameters over the study period. Because comparator-group details and key methodological details of the reported randomized design are not available in the source records, the findings should be considered preliminary and interpreted as evidence of short-term within-group improvement rather than comparative efficacy.
Downloads
Published
How to Cite
Issue
Section
Copyright (c) 2026 Vishesh Kumar kakar, Neeru Rani

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
